Smg1 haploinsufficiency predisposes to tumor formation and inflammation
Tara L. Roberts(Camden and Campbelltown Hospitals), Martin F. Lavin(Shandong First Medical University), Camile S. Farah(University of Queensland), Raymond A. Clarke(Ingham Institute), Simon H. Apte, Allison R. Pettit(Translational Research Institute), Rick Woods(QIMR Berghofer Medical Research Institute), Michael J. Waters(Royal Adelaide Hospital), Uda Ho(QIMR Berghofer Medical Research Institute), Liza J. Raggat(The University of Queensland), Phil Chen(QIMR Berghofer Medical Research Institute), Gethin Thomas(The University of Queensland), Carl A. Morrow(The University of Queensland), Kelli P. A. MacDonald(QIMR Berghofer Medical Research Institute), Liam St. Pierre(QIMR Berghofer Medical Research Institute), John Luff(The University of Queensland), C. Soon Lee(The University of Sydney), James A. L. Brown(Ollscoil na Gaillimhe – University of Galway)
Cited by 62
Related Papers
Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility
|Nature Genetics|2011|917
HIN-200 Proteins Regulate Caspase Activation in Response to Foreign Cytoplasmic DNA
|Science|2009|822
Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling
|Blood|2011|787
AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC
|Cell Death and Differentiation|2013|507